Evidence map›Paper›PMID 32039736›Full record

ReviewDiagnostic pathology2020

Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature.

Zhenwei Chen, Yihui Yang, Rongming Chen, Chi Sing Ng, Hongqi Shi

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Diagnostic pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.Journal of cancer research and clinical oncology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Primary pulmonary myxoid sarcoma: report of one case and literature review.International journal of clinical and experimental pathology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zhenwei ChenDepartment of Pathology, Jinhua Municipal Central Hospital, 351 Mingyue Road, Jinhua, 321000, Zhejiang Province, People's Republic of China.
Yihui YangDepartment of Pathology, Jinhua Municipal Central Hospital, 351 Mingyue Road, Jinhua, 321000, Zhejiang Province, People's Republic of China.
Rongming ChenDepartment of Pathology, the People's Hospital of Changfeng County, Changfeng County, Anhui Province, People's Republic of China.
Chi Sing NgDepartment of Pathology, St. Teresa's Hospital, Kowloon, Hong Kong. ngcspeter@gmail.com.ORCID http://orcid.org/0000-0002-0097-5479
Hongqi ShiDepartment of Pathology, Jinhua Municipal Central Hospital, 351 Mingyue Road, Jinhua, 321000, Zhejiang Province, People's Republic of China.
Jinhua Central Hospital · CNKowloon Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary pulmonary myxoid sarcoma (PPMS) is an extremely rare lung sarcoma that is characterized in most cases by recurrent balanced chromosomal translocation t(2;22)(q33;q12) leading to the oncogenic fusion gene EWSR1-CREB1. CASE PRESENTATION: We report a case of PPMS with molecular confirmation using fluorescence in situ hybridization (FISH) and DNA sequencing in a 45-year-old female patient. Computer tomography (CT) scanning revealed a peripheral circumscribed solid mass of 2.1 × 2 cm in the right lung superior lobe. Histologically, the tumor cells ranged from stellate, polygonal to chondrocyte-like or physaliferous-like, forming reticular network of delicate lace-like cellular strands and cords in abundant myxoid stroma. The tumor cell immunophenotype was positive for vimentin, EMA and negative for CK-pan, TTF-1, CAM5.2, S-100, calponin, SMA, desmin, ALK, CD31 and CD34. Molecular analysis demonstrated EWSR1-CREB1 gene fusion in this tumor. During 38 months of follow-up, the patient was alive with no clinical or radiological evidence of recurrence or metastasis.

conclusionPPMS is a rare low-grade sarcoma with distinct histological and genetic features. We add another case to the literature of this rare tumor and report for the first time occurrence of chondrocyte-like and physaliferous-like tumor cells in this tumor, thus enriching its morphologic and cytologic spectrum.

Indexed as

Biomarkers, TumorCyclic AMP Response Element-Binding ProteinFemaleHumansMiddle AgedNeoplasm Recurrence, LocalRNA-Binding Protein EWSSarcomaSoft Tissue NeoplasmsBiomarkers, TumorCREB1 protein, humanCyclic AMP Response Element-Binding ProteinEWSR1 protein, humanRNA-Binding Protein EWSChondrocyte-likeCREB1EWSR1MyxoidPhysaliferous-likePulmonarySarcoma

Identifiers

PMID32039736
PMCPMC7008573
OpenAlexW3008847135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.